June 22, 2026

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Ups and Downs in a Dynamic Healthcare Market

Oscar Health, Inc. (OSCR) presents an intriguing opportunity for investors interested in the dynamic healthcare sector. As a healthcare technology company, Oscar Health is at the forefront of offering innovative..

Centene Corporation (CNC) Stock Analysis: Navigating Growth in the Healthcare Sector with a Market Cap of $30.13 Billion

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, continues to capture investor attention with its robust market capitalization of $30.13 billion. Headquartered in Saint Louis, Missouri,..

McKesson Corporation (MCK) Stock Analysis: A Potential 25% Upside Amid Robust Revenue Growth and Strong Buy Ratings

As one of the largest and most diversified healthcare services companies in the world, McKesson Corporation (NYSE: MCK) holds a commanding position in the medical distribution industry. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A $10.26 Billion Market Cap Player in Gene Therapy with Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has been making waves in the biotechnology sector, drawing attention from investors with its innovative approach to genetic medicine. With a current market capitalization of..

The Ensign Group (ENSG) Stock Analysis: Unveiling a 43% Upside Potential in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG) has been garnering attention in the medical care facilities industry for its robust growth and promising future prospects. Operating across multiple states in the..

Investor Outlook: Jazz Pharmaceuticals plc (JAZZ) and Its 14.40% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology industry, continues to draw attention from investors with its robust pipeline and significant market presence. Based in Dublin, Ireland,..

Elanco Animal Health (ELAN) Stock Analysis: 23% Potential Upside Beckons Investors

Elanco Animal Health Incorporated (NYSE: ELAN), a significant player in the healthcare sector focused on animal health, presents a compelling opportunity for investors seeking exposure in the drug manufacturing industry...

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Potential 44% Upside Amid Promising Pipeline and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its robust growth potential and significant upside opportunity. With a market capitalization of $6.64 billion, this Boston-based biopharmaceutical..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 52.64% Potential Upside Beckons Investors

Investors keen on the biotechnology sector might find BeOne Medicines Ltd. (NASDAQ: ONC) a compelling opportunity. With a market cap of $28.03 billion, this Switzerland-based oncology company is making waves..

Cencora, Inc. (COR) Stock Analysis: Understanding Its 28.97% Upside Potential

Cencora, Inc. (NYSE: COR), a major player in the healthcare sector, is attracting significant investor attention due to its compelling 28.97% potential upside based on current analyst ratings. As a..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 52.84% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS), a stalwart in the healthcare sector, is catching the attention of investors with its strong market presence and promising growth potential. Operating primarily in..

Gilead Sciences, Inc. (GILD) Investor Outlook: 27% Upside Potential and Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) presents a compelling investment case for those seeking stability in the healthcare sector, coupled with promising growth prospects. With a market capitalization of $153.66 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector

For investors looking to deepen their portfolios within the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. With a market capitalization of $4.79 billion, this Italy-based company..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector, capturing investor attention with its innovative treatments for B-cell mediated diseases. With a market cap of $8.15 billion,..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 10.12% Upside in Biotech

Corcept Therapeutics Incorporated (NASDAQ: CORT) emerges as a compelling player in the biotechnology sector, currently commanding a market capitalization of $8.58 billion. Specializing in the development of therapies for severe..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 14.82% Upside Potential Amid Growing Revenue

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $13.04 billion, the company is a..

Dr. Reddy’s Laboratories Ltd (RDY): Analyst Consensus and Growth Potential Amidst Market Volatility

In the ever-evolving landscape of the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player, offering a diverse range of products across global markets. With a..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 106% Upside Potential in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology industry, with a strategic focus on developing innovative cell therapies to combat oncology and other serious diseases. Headquartered..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Unlocking a 20% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a renowned name in the healthcare sector, stands prominently in the medical instruments and supplies industry. With a market capitalization of $5.3 billion, this..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 17.12% Potential Upside with Solid Dividend Yield

Investors with a keen eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an intriguing option, as this pharma giant continues to showcase robust growth prospects and a..

Search

Funds

June 22, 2026

Search

Funds

June 22, 2026

FTSE 100

Funds